Hospira Inc. FDA Record
- Latest inspection NAI · Aug 22, 2025
- 62 Class I recalls
- Last warning letter 2017
Hospira Inc. has 257 FDA recalls (62 Class I), 50 inspections, 45 510(k) clearances and 3 compliance actions on record. FDA has issued 3 warning letters to Hospira Inc., the most recent on Feb 14, 2017. FDA has published 9 Form 483s for Hospira Inc..
- Latest recall
- D-0052-2027 · Sep 29, 2026 · filed under Pfizer
- Latest recall under this name
- D-0862-2017 · Class I · Apr 21, 2017
- Latest inspection
- Aug 22, 2025 · NAI
- Latest 510(k)
- Mar 28, 2017
Newer recall under related name Pfizer: Sep 29, 2026, D-0052-2027.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 257 (62 Class I) | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 45 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 50 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 3 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
Hospira Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 3 | 0 | 0 | 0 | 0 |
| 2024 | 2 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 2 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 2 | 1 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 1 | 1 | 1 |
Reviewing Hospira Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Hospira Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Hospira Inc. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Feb 14, 2017 · Record page | |||
| Mar 7, 2014 · Record page | |||
| Aug 12, 2009 · Record page |
Hospira Inc. Form 483s
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0862-2017 | Class I | Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per… | Apr 21, 2017 |
| D-0153-2017 | Class II | Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira… | Nov 1, 2016 |
| D-1500-2016 | Class II | DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV Use Only, Must be Diluted Prior to Use… | Aug 15, 2016 |
| D-0169-2017 | Class III | 5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only… | Jun 29, 2016 |
| D-1359-2016 | Class II | Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC… | Jun 23, 2016 |
| D-1033-2016 | Class II | Vancomycin Hydrochloride for Injection, USP, 10 g, 100 mL vial, Rx only, Hospira, Lake Forest, IL… | May 6, 2016 |
| Z-1832-2016 | Class II | The Plum 360 is a large volume infuser capable of delivering fluids for a variety of therapies such… | Mar 25, 2016 |
| Z-1833-2016 | Class II | The Plum A+ is a dual-line volumetric infusion system designed to meet the growing demand for… | Mar 25, 2016 |
| D-0854-2016 | Class III | Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial… | Mar 23, 2016 |
| D-1137-2016 | Class I | Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial… | Mar 23, 2016 |
| D-0865-2016 | Class I | 8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx only… | Mar 18, 2016 |
| D-0836-2016 | Class III | Quelicin (Succinylcholine Chloride) Injection, USP 200 mg. (20 mg/mL), 10 mL Multiple-dose vial… | Mar 15, 2016 |
| D-0831-2016 | Class II | Mannitol I.V., 20%, USP (20 g/ 100 mL), Packaged in 250 mL Bags, Rx Only, Hospira, Inc., Lake… | Mar 8, 2016 |
| D-0828-2016 | Class II | Dextrose Injection, USP, 50%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc., Lake… | Mar 8, 2016 |
| D-0827-2016 | Class II | Dextrose Injection, USP, 70%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc., Lake… | Mar 8, 2016 |
| D-0832-2016 | Class II | Potassium Chloride Injection 20 mEq, 400 mEq/L, Packaged in 50 mL Bags, Rx only, Hospira, Inc., Lake… | Mar 8, 2016 |
| D-0830-2016 | Class II | Aminosyn-PF (amino acids) 7%, Sulfite-Free, 500 mL Bags, Rx Only, Hospira, Inc., Lake Forest, IL… | Mar 8, 2016 |
| D-0829-2016 | Class II | Dextrose Injection, USP, 20%, Packaged as 500 mL in 1000 mL Bags, Rx only, Hospira, Inc., Lake… | Mar 8, 2016 |
| D-0727-2016 | Class III | Normosol-M and 5% Dextrose (multiple electrolytes and 5% dextrose) Injection Type 1, USP, 1000 mL… | Feb 2, 2016 |
| D-0668-2016 | Class I | Magnesium Sulfate in Water for Injection, (0.325 mEq Mg++/mL) 40 mg/mL, 2 g Total, 50 mL Single-Dose… | Jan 5, 2016 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Aug 22, 2025 | Lake Forest, IL | Drugs | No Action Indicated (NAI) | 3004591926 |
| Feb 7, 2025 | Rocky Mount, NC | Drugs | No Action Indicated (NAI) | 1021343 |
| Jan 17, 2025 | Mcpherson, KS | Drugs | Voluntary Action Indicated (VAI) | 1925262 |
| Jun 7, 2024 | Lake Forest, IL | Biologics | No Action Indicated (NAI) | 3004591926 |
| Mar 27, 2024 | Mcpherson, KS | Biologics | No Action Indicated (NAI) | 1925262 |
| Feb 27, 2020 | Lake Forest, IL | Drugs | No Action Indicated (NAI) | 3004591926 |
| Jan 17, 2020 | Mcpherson, KS | Drugs | Voluntary Action Indicated (VAI) | 1925262 |
| Nov 21, 2019 | Rocky Mount, NC | Drugs | Voluntary Action Indicated (VAI) | 1021343 |
| Aug 15, 2018 | Mcpherson, KS | Drugs | Official Action Indicated (OAI) | 1925262 |
| Feb 2, 2018 | Rocky Mount, NC | Devices | Voluntary Action Indicated (VAI) | 1021343 |
| Oct 27, 2017 | Mcpherson, KS | Veterinary | Voluntary Action Indicated (VAI) | 1925262 |
| Jun 8, 2016 | Mcpherson, KS | Drugs | Official Action Indicated (OAI) | 1925262 |
| May 26, 2016 | Rocky Mount, NC | Drugs | No Action Indicated (NAI) | 1021343 |
| Nov 19, 2015 | Haina, San Cristobal, Dominican Republic (The) | Devices | No Action Indicated (NAI) | 3002806326 |
| Sep 24, 2015 | Rocky Mount, NC | Devices | Voluntary Action Indicated (VAI) | 1021343 |
| Apr 13, 2015 | Lake Forest, IL | Drugs | Voluntary Action Indicated (VAI) | 3004591926 |
| Apr 3, 2015 | Mcpherson, KS | Drugs | Voluntary Action Indicated (VAI) | 1925262 |
| Dec 9, 2014 | Lake Forest, IL | Veterinary | No Action Indicated (NAI) | 3004591926 |
| Jun 13, 2014 | Rocky Mount, NC | Veterinary | No Action Indicated (NAI) | 1021343 |
| Apr 23, 2014 | Mcpherson, KS | Veterinary | No Action Indicated (NAI) | 1925262 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 3 compliance actions under Hospira Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3004591926 | Lake Forest, IL | 10 | Aug 22, 2025 |
| FEI 1021343 | Rocky Mount, NC | 12 | Feb 7, 2025 |
| FEI 1925262 | Mcpherson, KS | 17 | Jan 17, 2025 |
| FEI 3002806326 | Haina, San Cristobal, Dominican Republic (The) | 3 | Nov 19, 2015 |
| FEI 1048698 | Clayton, NC | 6 | Jun 13, 2013 |
| FEI 2921482 | Morgan Hill, CA | 2 | Jul 28, 2010 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K161469 | Plum 360(TM) Infusion System with MedNet/ Smart Card Plug and Play Module | Mar 28, 2017 |
| K161036 | Hospira Extension Set, Hospira Primary Set | Jan 6, 2017 |
| K160492 | Hospira Sapphire Sets | Dec 6, 2016 |
| K160870 | Hospira Administration Sets | Jun 1, 2016 |
| K143612 | LifeCare PCA Infusion System | Apr 8, 2016 |
| K143087 | Hospira Blood Set | Mar 4, 2015 |
| K143015 | Hospira Primary Sets | Feb 25, 2015 |
| K141789 | PLUM 360 INFUSION SYSTEM WITH HOSPIRA MEDNET, SMART CARD PLUG N PLAY CE 3.0 MODULE FOR PLUM A+… | Jan 16, 2015 |
| K142622 | IV Administration | Jan 15, 2015 |
| K142974 | Extension Sets | Jan 9, 2015 |
| K142433 | Hospira Extension Set | Dec 8, 2014 |
| K142367 | Hospira Primary Sets | Nov 25, 2014 |
| K141102 | HOSPIRA MEDNET MEDICATION MANAGEMENT SUITE | Jul 8, 2014 |
| K133602 | ADD-VANTAGE ADDAPTOR | Jan 24, 2014 |
| K132276 | STERILE EMPTY GLASS CONTAINER, 250ML, STERILE EMPTY GLASS CONTAINER, 500 ML, STERILE EMPTY GLASS… | Nov 12, 2013 |
| K121032 | PRIMARY SYMBIQ SET, DITAL MICROBORE TUBING, 0.2 MICRON FILTER, NON-DEHP | Jun 21, 2012 |
| K110901 | SYMBIQ INFUSION AND ADMINSTRATION SET | Mar 5, 2012 |
| K113683 | LIFESHIELD VISION INFUSION SET WITH PRE-PIERCED RESEAL | Jan 12, 2012 |
| K103224 | HOSPIRA PLUM INFUSION SET; HOSPIRA INFUSION SET WITH YELLOW STRIPE TUBING | Jan 7, 2011 |
| K103344 | INFUSION SETS | Dec 10, 2010 |
Hospira Inc. and the FDA: common questions
Has Hospira Inc. received an FDA warning letter?
Yes. FDA has issued 3 warning letters to Hospira Inc.. The most recent is dated Feb 14, 2017.
Has Hospira Inc. received an FDA Form 483?
FDA has published 9 Form 483s for Hospira Inc. in its reading room, the most recent dated Mar 10, 2026. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Hospira Inc.?
The most recent FDA inspection on file ended Aug 22, 2025 at Lake Forest, IL and was classified NAI. FDA has 50 inspections of Hospira Inc. on file, 6 of them classified OAI (official action indicated).
Has Hospira Inc. had an FDA recall?
Yes. Hospira Inc. has 257 FDA recalls on record, 62 of them Class I, the most serious class. The most recent under this name started Apr 21, 2017. A newer recall, dated Sep 29, 2026, is filed under the related name Pfizer.
Need more than this page shows? Ask about Hospira Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.